President Donald Trump has signed the so-called "right-to-try" bill into law, and claimed that it would result in lower drug prices within weeks; New Jersey will implememt a statewide individual mandate requiring residents to have health insurance or pay a fee; in the United States, poor people are dying younger, with low socioeconomic status leading to people being sicker and dying earlier.
The so-called “right-to-try” bill, which helps people with deadly illnesses try experimental treatments, has been signed into law. President Donald Trump supported such efforts to improve access to treatments during his presidential campaign, and the bill will allow patients with no other treatment options to access drugs that have not yet been approved by the FDA, reported The Associated Press. After signing the bill, Trump claimed that drug makers will voluntarily make big drug price cuts in just a few weeks, reported Politico. However, industry sources said they had no knowledge of what caused the president to say that.
New Jersey will now require all residents to have health insurance or pay a fee. According to the Newark Star-Ledger, the bill’s sponsor said the state mandate would stabilize the insurance market and allow the Affordable Care Act to continue to be successful in New Jersey. Fees collected from people who choose not to have health insurance will be deposited in a fund to help pay the claims of people who are very sick in order to keep rates from rising dramatically.
In the United States, poor people are dying younger, with low socioeconomic status leading to people being sicker and dying earlier. The Washington Post reported that an analysis of data found the increased likelihood of poorer people dying earlier means they have less political impact to pursue policies that could help improve their health or lengthen their lives. In addition, these disparities are worse in the United States than in other developed countries.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More